- Clinical Trials
- April 2024
- 60 Pages
Global
From €1136EUR$1,250USD£973GBP
- Report
- January 2024
- 99 Pages
Global
From €3500EUR$4,125USD£3,102GBP
- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
Pentoxifylline is a cardiovascular drug used to treat peripheral vascular disease, intermittent claudication, and other conditions. It works by increasing the flexibility of red blood cells, allowing them to flow more easily through narrowed blood vessels. It also helps to reduce inflammation and improve blood flow. Pentoxifylline is available in both oral and intravenous forms.
The pentoxifylline market is highly competitive, with a number of companies offering generic and branded versions of the drug. Companies such as Pfizer, Novartis, and Mylan are among the leading manufacturers of pentoxifylline. Other companies such as Teva Pharmaceuticals, Sandoz, and Actavis also offer generic versions of the drug.
In addition, there are a number of specialty pharmaceutical companies that offer pentoxifylline in combination with other drugs. These companies include Merck, GlaxoSmithKline, and Sanofi. These companies offer combination products that are designed to provide more effective treatment for certain conditions. Show Less Read more